Breast Cancer News

Healio spoke with Paolo Tarantino, MD, about treatments in the pipeline for metastatic breast cancer.

Paolo Tarantino, MD, discusses the role of collaborative management of patients with metastatic breast cancer.

Healio spoke with Paolo Tarantino, MD, about FDA approvals in metastatic breast cancer.

The FDA has approved trastuzumab-strf as a biosimilar to trastuzumab for the treatment of certain patients with HER2-overexpressing malignancies, according to a press release from the agent’s manufacturer.

Women should be screened for breast cancer every other year starting at age 40 years, according to a new recommendation statement from the U.S. Preventive Services Task Force.

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

Compared with standard-of-care chemotherapy, trastuzumab deruxtecan demonstrated a statistically significant improvement in PFS among certain patients with metastatic breast cancer, according to a press release from the manufacturer.

Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.

Women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if diagnosis occurred within 10 years postpartum, according to cohort study results published in JAMA Network Open.

Less than half of the cancer therapies granted FDA accelerated approval showed meaningful improvement in survival or quality-of-life, study results presented at American Association for Cancer Research Annual Meeting showed.